Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-04-23 @ 7:09 PM
Study NCT ID:
NCT05955105
Status:
RECRUITING
Last Update Posted:
2024-05-21
First Post:
2023-07-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies
Sponsor:
Innolake Biopharm
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CILB2109A102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None